![Svetlana Lucas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Svetlana Lucas
Direktor/Vorstandsmitglied bei
ATYR PHARMA, INC.
Vermögen: 969 057 $ am 31.08.2026
Profil
Dr. Svetlana Lucas is an Independent Director at Jasper Therapeutics, Inc., an Independent Director at aTyr Pharma, Inc. and a Chief Business Officer at Scribe Therapeutics, Inc. She is on the Board of Directors at Jasper Therapeutics, Inc. and aTyr Pharma, Inc. Dr. Lucas was previously employed as a Senior Vice President-Business Development by Tizona Therapeutics, Inc. and a Head-Oncology & Inflammation by Amgen, Inc. She received her undergraduate degree from Moscow State University Lomonosov and a doctorate degree from California Institute of Technology.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SCRIBE THERAPEUTICS INC. 0,16 % | 27.07.2026 | 30.695 ( 0,16 % ) | 937 425 $ | 31.08.2026 |
| 10.08.2026 | 40.000 ( 0,12 % ) | 28 440 $ | 31.08.2026 | |
ATYR PHARMA, INC. 0,01 % | 27.08.2026 | 6.000 ( 0,01 % ) | 3 192 $ | 31.08.2026 |
Aktive Positionen von Svetlana Lucas
| Unternehmen | Position | Beginn |
|---|---|---|
| ATYR PHARMA, INC. | Direktor/Vorstandsmitglied | 28.06.2019 |
| SCRIBE THERAPEUTICS INC. | Corporate Officer/Principal | 01.06.2019 |
| JASPER THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 19.06.2024 |
Ehemalige bekannte Positionen von Svetlana Lucas
| Unternehmen | Position | Ende |
|---|---|---|
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Corporate Officer/Principal | 01.01.2019 |
| AMGEN INC. | Corporate Officer/Principal | 01.07.2015 |
Ausbildung von Svetlana Lucas
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
80
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
aTyr Pharma, Inc.
 aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moscow State University Lomonosov
 Moscow State University Lomonosov Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Health Technology |
Scribe Therapeutics, Inc.
 Scribe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops CRISPR-based genetic medicines to extend healthy lifespan through disease prevention and durable therapeutic interventions | Health Technology |
Jasper Therapeutics, Inc.
 Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
